Five Themes For Korean Biopharma In 2025

US Approvals, New Modalities, Obesity

 
• By Jung Won Shin
  
Scrip Perspectives - new chapter
Korean Industry Entering A New Growth Chapter Despite Political Uncertainties (Shutterstock)

More from South Korea

More from Scrip Perspectives